We Stopped Pfizer’s Tax Dodge, Now Let’s End the Buybacks
Why companies, particularly ones that get large taxpayer subsidies like Pfizer, should not be allowed to manipulate their stock prices thorough buybacks.
Read more...Why companies, particularly ones that get large taxpayer subsidies like Pfizer, should not be allowed to manipulate their stock prices thorough buybacks.
Read more...After Wisconsin, the next round of primaries in concentrated in more affluent East Coast states, and Clinton does well with rich voters. Can Sanders make enough headway with them?
Read more...Rebellion watch: Why the natives will remain restless.
Read more...By linking immigration and trade, however crudely, Trump has exposed the broader paradox and inherent contradictions which lurk between the two.
Read more...Make no mistake; the Democrats engineered the Third Way faux liberalism that sold out the working classes to benefit the rich and their minions.
Read more...A well-meaning effort to analyze rent-seeking goes off the rails.
Read more...How McKinsey contributed to the devolution of Big Pharma.
Read more...Bill Black is not happy about the revisionist history on liar’s loans. And separately, this piece is a useful exercise in the critical reading of narratives.
Read more...Trump represents a new strain in American politics: low wage full employment and the protection of the status of big business through violent discipline.
Read more...Hillary as a neoliberal is not your friend….unless you are a member of the 1% or on their meal ticket.
Read more...Today’s richest Americans may soon blow past the tycoons of the Roaring Twenties.
Read more...How citizens must fight plutocrats if they are to have any hope of preserving rule by the people.
Read more...“Managerialism” is a form of looting: coast on an established brand name and goodwill while degrading the actual service in order to pay the top executives more.
Read more...A former state official shreds the process CalPERS used to hire scandal-ridden Florida attorney Robert Klausner as fiduciary counsel.
Read more...Pfizer whines about needing higher drug prices, when rather than investing, it has spent over 100% of its profits on stock buybacks and dividends.
Read more...